Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
3 Solid Stocks to Buy for Superb Earnings Acceleration
07:31am, Wednesday, 18'th Oct 2023
Invest in stocks such as Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN) and Inari Medical (NARI) for solid earnings acceleration.
Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapse
02:17pm, Monday, 16'th Oct 2023
The FDA accepts Catalyst's (CPRX) sNDA to increase the indicated maximum daily dosage of Firdapse 10 mg from 80mg to 100mg for treating Lambert-Eaton myasthenic syndrome. The decision is due on Jun 4,
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
10:31am, Thursday, 12'th Oct 2023
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
New Strong Buy Stocks for October 11th
09:02am, Wednesday, 11'th Oct 2023
PBF, PRAX, CPRX, MFA and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 11, 2023.
4 Stocks That Exhibit Solid Earnings Acceleration
09:01am, Friday, 06'th Oct 2023
Invest in stocks like Catalyst Pharmaceuticals (CPRX), ImmunoGen (IMGN), Inari Medical (NARI) and Kyndryl Holdings (KD) for superb earnings acceleration.
Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference
08:03am, Monday, 18'th Sep 2023
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and
Why Is Catalyst (CPRX) Down 14% Since Last Earnings Report?
12:47pm, Friday, 08'th Sep 2023
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Catalyst (CPRX) Q2 Earnings & Sales Top, 2023 Outlook Raised
12:17pm, Friday, 11'th Aug 2023
Catalyst (CPRX) reports better-than-expected second-quarter 2023 results. Management raises full-year 2023 guidance.
7 ‘Strong Buy' Value Stocks You Should Be Loading Up On Now
02:44pm, Thursday, 03'rd Aug 2023
Inherently, investors gravitate toward strong buy value stocks, in much the same way that audience members of a horror film might grip their armrests. As humans, we're basically hardwired – especial
Deerfield Management Company, L.P.
10:03pm, Tuesday, 01'st Aug 2023
Deerfield Management Company, L.P. (Series C), a renowned investment firm, recently made a significant addition to its portfolio.
Catalyst Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 9, 2023
08:03am, Monday, 24'th Jul 2023
The Company to Host a Conference Call and Webcast on August 10, 2023, at 8:30 AM ET The Company to Host a Conference Call and Webcast on August 10, 2023, at 8:30 AM ET
Catalyst Pharmaceuticals: Expecting Higher FIRDAPSE Revenues In A Year
09:39pm, Tuesday, 04'th Jul 2023
The company reported record revenues of $85.4 million in 1Q 2023, a 98% YoY increase, and expects its 2Q, 3Q, and 4Q 2023 revenues to be higher than in 1Q. The company estimates about 10% of the patie
Catalyst Pharmaceuticals: Cheap For A Reason
06:49am, Monday, 03'rd Jul 2023
We check in on Catalyst Pharmaceuticals today as a lot has happened around the company since we last looked at it last summer. These include a major addition to the company's pipeline, challenges on t
7 Little-Known Stocks to Buy Now Before They Become the Next Big Thing
01:46pm, Sunday, 02'nd Jul 2023
While acquiring little-known stocks can be a scary proposition, you should also realize that going with the predictable also has its risks. Fundamentally, anytime you enter the capital markets, you're
Is the Options Market Predicting a Spike in Catalyst Pharmaceuticals (CPRX) Stock?
10:21am, Thursday, 22'nd Jun 2023
Investors need to pay close attention to Catalyst Pharmaceuticals (CPRX) stock based on the movements in the options market lately.
